- AU$206.36m
- AU$169.56m
- AU$387.35m
Australia blocks takeover of Mayne Pharma by Cosette on national interest grounds (updated)
Australia blocks Cosette Pharmaceuticals bid to buy Mayne Pharma
Brief: Mayne Pharma Seeks Trading Halt
Brief: Mayne Pharma Updates On Status Of FIRB Approval & Second Court Hearing
Australia's Mayne soars as Takeovers Panel clamps down on Cosette bid, reviving deal hopes
Brief: Australia's Takeovers Panel Makes Declaration Of Unacceptable Circumstances On Mayne Pharma's Application
Brief: Mayne Pharma Group Says FIRB Extends Deadline For Decision To 20 November 2025
Brief: Australian Government Takeovers Panel Decided To Conduct Proceedings For Application Dated 6 November
Brief: Mayne Pharma Group Seeks Trading Halt
Brief: Mayne Pharma Group Updates On Status Of FIRB Approval
Brief: Australian Government Takeovers Panel Receives Application From Mayne Pharma
Mayne Pharma shares dive after Australia's treasurer considers blocking Cosette bid (updated)
Australia's Mayne Pharma falls as treasurer considers blocking Cosette's $437 million bid (updated)
Corrected: UPDATE 1-Australian treasurer weighs blocking Mayne Pharma's $437 million takeover
Brief: Mayne Pharma Updates On Scheme Of Arrangement Update On FIRB Approval
Banks, miners propel Australian shares to snap three-day losing streak
Australian treasurer weighs blocking Mayne Pharma's $437 million takeover (updated)
Australia's Mayne Pharma eyes worst day ever as Treasurer weighs blocking its buyout
Australian treasurer weighs blocking Mayne Pharma's $437 million takeover